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RESEARCH ARTICLE
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Abstract
Autotaxin (ATX) is a secreted enzyme that generates the bioactive lipid lysophosphatidic
acid (LPA). We generated mice with global inducible post-natal inactivation or adipose-spe-
cific loss of the Enpp2 gene encoding ATX. The animals are phenotypically unremarkable
and exhibit differences in adipocyte size and adipose tissue expression of inflammatory
genes after high fat feeding without gross differences in fat distribution or body mass. Sur-
prisingly, both models of Enpp2- deficiency exhibited marked protection from high fat diet-
induced hepatic steatosis. This phenotype was not associated with differences in dietary fat
absorption but may be accounted for by differences in hepatic expression of genes involved
in de novo synthesis of triglycerides. These findings suggest that pharmacological inhibition
of ATX might be protective against hepatic steatosis.
Introduction
The ectonucleotide pyrophosphatase /phosphodiesterase 2 (ENPP2), also referred to as auto-
taxin (ATX), is a secreted lysophospholipase D (lysoPLD) that catalyzes the hydrolysis of circu-
lating or cell-associated lysophosphatidylcholine (LPC) to generate the bioactive lipid
mediator lysophosphatidic acid (LPA). ATX was originally identified as cell motility factor for
cancer cells [1], has an identified role in vascular development [2–4], and serves as a marker
and potential mediator of fibrosis [5–7] and inflammation [8–11]. Most, if not all, of its bio-
logic effects appear to be mediated by the generation of LPA, which has broad ranging and
potent, receptor-mediated effects on cells. Indeed, LPA promotes cell growth, differentiation,
apoptosis and development [12, 13], largely through effects on a family of G-protein-coupled
LPA receptors with at least six bona fide members (LPA1-6 receptors) and potentially also
through the immunoglobulin family receptor for advanced glycan end products (RAGE) [14].
ATX can also bind cell surface receptors, such as integrins [15–18], raising the possibility of
LPA-independent effects on cell adhesion and motility.
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ATX contains a consensus signal sequence, which is expressed as a transmembrane protein
and after processing and secretion undergoes classic processing for extracellular secretion, and
is found in most biologic fluids, including plasma. Multiple cells secrete ATX, with adipocytes
contributing substantially to levels in circulation [19, 20]. Adipocytes express and secrete ATX
during differentiation [21], in a manner that requires gp130 [22]. Both visceral and subcutane-
ous fat contain mRNA for ATX, and the expression is largely restricted to adipocytes with little
to no expression observed in stromal vascular cells (preadipocytes, mesenchymal stem cells,
endothelial progenitor cell, T cells, B cells, mast cells and adipose tissue macrophage). AP2
Cre-specific ablation of the Enpp2 gene lowers ATX concentrations in plasma [20], suggesting
that adipocytes are an important source of circulating ATX. In keeping with these observations
and the role of ATX and LPA in inflammation, the enzyme has been proposed as a novel adi-
pokine. However, its precise function in the context of obesity is not clear. Some have reported
that with obesity, ATX expression increases particularly in subcutaneous fat depots [19] and
others have suggested that ATX mRNA levels are higher in adipose from individuals with insu-
lin resistance [23]. However, there are reports that adipose ATX expression decreases in obese
subjects [24]. Finally, plasma LPA and ATX levels may positively correlate with body mass
index [21, 23, 25]. A similar degree of controversy exists in rodents. ATX mRNA levels are
higher in adipose tissue of obese db/db mice. We previously demonstrated that transgene-
driven overexpression of ATX promotes adiposity and hepatic steatosis in mice [26]. However,
there have been conflicting reports about whether reductions in ATX levels protect [24] or
promote [20] adipose tissue expansion in obese mice. To reconcile these observations and to
determine if adipose-derived ATX serves as a novel inflammatory mediator of obesity, we
compared the phenotype of mice with systemic reductions in ATX levels postnatally with mice
lacking adipose-derived ATX. Our findings suggest that ATX promotes local tissue inflamma-
tion and that adipose-derived ATX fundamentally regulates steatosis and lipid remodeling




All procedures conformed to the recommendations of “Guide for the Care and Use of Labora-
tory Animals” [27] and were approved by the Institutional Animal Care and Use Committee at
the University of Kentucky. Mice are monitored daily by trained veterinary staff and animal
facility personnel for pain and discomfort. Any mice showing signs of distress that fail to
respond to treatments recommended by a veterinarian were promptly euthanized. Systemic
post-natal reduction in ATX expression was achieved by crossing mice containing loxP sites
flanking exons 3 and 4 of Enpp2 (fl/fl; previously backcrossed to C57BL/6) with B6.Cg-Tg
(Mx1-cre; Jackson Laboratories) mice expressing Cre-recombinase under the control of the
MX-1 promoter. At postnatal day 3–5, littermate fl/fl mice with and without the MX1-Cre
were treated with polyinosinic:polycytidylic acid (pI-pC), which activates MX-1 to drive Cre
expression and globally reduce ATX expression to generate MX1-Δ animals. ATX expression
in adipocytes was targeted by crossing fl/fl mice with B6;FVB-Tg(Adipoq-cre; Jackson Labora-
tories) mice expressing Cre under the control of the adiponectin promoter (Adipoq). Mice
were genotyped and weaned at 21 d, maintained on a 14-h light and 10-h dark cycle. At 5–6
weeks of age, littermates were assigned to either normal chow (2018 Teklad 18% rodent diet,
Envigo, 2018C) or high fat diet (HFD; 60% of calories are from lard fat; Research Diet,
D12492) and fed the diet ad-libitum for 20 weeks. Mice were euthanized using isoflurane over-
dose. Organs were isolated, weighed, and washed once with PBS prior to processing. An
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EchoMRI-100 Whole Body Composition Analyzer (University of Kentucky, Lexington, KY)
was used to measure total fat and lean mass as previously described [26].
Plasma cholesterol, triglyceride, ATX activity, and biomarkers
Total plasma cholesterol was measured using the Wako Diagnostics Cholesterol E Assay and
triglycerides (TG) using the Wako Diagnostics L-type TG M Assay and the Multi-Calibrator
Lipid Standard to generate a standard curve according to the manufacturer’s protocol. ATX
activity was measured by choline release assay [28] in which choline is oxidized to betaine and
hydrogen peroxide, the latter reacts with TOOS (N-ethyl- N-(2-hydroxy-3-sulfopropyl)-3
methylaniline) and 4-AAP (aminoantipyrene) to form quinoneimine dye which can be mea-
sured at Abs 555 nm every 5 minutes for 20 minutes. To establish background choline levels, a
potent ATX inhibitor was included in triplicate samples. For each sample, the absorbance was
plotted against time and the slope (dA/min) was calculated for the linear (steady-state) portion
of each reaction. ATX activity was calculated according to the following equation: Activity (U/
ml) = (μmol/ min/ ml) = [dA/ min (sample)—dA/ min (blank)] � Vt/ (e� Vs� 0.5) where Vt:
total volume of reaction (ml), Vs: volume of sample (ml), e: milimolar extinction coefficient of
quinoneimine dye under the assay conditions (e = 32,8 μmol/ cm2) and 0.5: the moles of qui-
noneimine dye produced by 1 mol of H2O2. Immunoblotting for ATX was performed with a
polyclonal antibody (AB#10005375, Cayman Chemicals). Plasma biomarkers were measured
in EDTA-anticoagulated blood by Multiplex assay.
Glucose, insulin, and lipid tolerance testing
Intraperitoneal glucose tolerance test was performed in the afternoon after a 5-h fasting. After
baseline glucose measurements were taken, mice were injected i.p. with glucose (2 g/kg body
weight) in isotonic saline, and serial measurements of glucose level were taken at 7, 15, 30, and
120 min. Intraperitoneal insulin tolerance test was performed in the afternoon after a 5-h fast-
ing. After baseline glucose measurements were taken, mice were injected i.p. with insulin (2 g/
kg body weight) in isotonic saline, and serial measurements of glucose level were taken at time
points up to 120 min. Dietary fat absorption was measured using a modification of a previously
described method [29] that involves feeding mice diets containing poorly absorbed sucrose
fatty acid esters that can be measured in feces along with other diet derived fatty acids. Nor-
malized fat absorption can then be calculated from the ratio of free and esterified fatty acids in
the diet and feces to the sucrose fatty acid ester measured in the same samples after measure-
ment by GC MS.
Histology
For adipocyte cell size, slides containing frozen fat tissue sections (subcutaneous and visceral)
were stained with BODIPY dye. Cell area determined after imaging on a Nikon A1R confocal
microscope with a spectral detector and analysis performed using NIKON NIS software (Mel-
ville, NY) where 100 cells/tissue/mouse were measured.
Quantitative Real-time PCR
Organs were collected from mice and weighed. A representative piece from taken from similar
locations in each organ was immediately cut and stored in RNAlater (Thermo Fisher Scientific,
Waltham, MA, Ca# AM7021). The tissues were homogenized and total RNA was extracted
using Trizol (Thermo Fisher Scientific, cat# 15596018). cDNA was prepared with Multiscribe
reverse-trasncriptase enzyme (High Capacity cDNA Archive Kit; Thermo Fisher Scientific).
Autotaxin regulates complications of diet-induced obesity
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mRNA expression was measured in real-time quantitative PCR using predesigned TaqMan
gene expression assays (Thermo Fisher Scientific) as indicated in S1 Table. All the probes used
in the study spanned an exon junction and thus would not detect genomic DNA. An RNA
sample without reverse transcription was used as a negative control. Samples were assayed on
a Quantstudio 7 flex (Applied Biosystems). Threshold cycles (CT) were determined by an in-
program algorithm assigning a fluorescence baseline based on readings prior to exponential
amplification. Fold change in expression was calculated using the 2-δδCT method using 18s
RNA as an endogenous control.
Lipidomics
Lipids were extracted from tissue using acidified organic solvents with inclusion of lipid class
specific internal standards. The lipid containing organic phase was evaporated to dryness,
reconstituted and analyzed by direct infusion mass spectrometry using an AB Sciex 5600
(Sciex, Framingham, MA) quadrupole time of flight mass spectrometer and adaptations of pre-
viously described methods [30, 31]. In brief data were collected in positive and negative mode
with collection of a survey scan followed by sequential precursor ion selection and fragmenta-
tion at unit mass increments in the range m/z 200–1,200. The data were processed using AB
Sciex LipidView software (Sciex) with a mass tolerance set to 0.3 mDa and spectral peaks
exceeding 2 times the signal to noise threshold included. The software identifies lipids from
their accurate molecular ion mass, isotope pattern and product ion spectra. After inspection of
the primary data, lipid species detected in all technical replicates were quantitated by reference
to their cognate lipid class specific internal standard. Although these experiments necessarily
identify a large number of molecular species within each lipid class for simplicity the data pre-
sented are a sum of all lipid species within a particular class normalized to the starting weight
of the tissue.
Statistical analysis
All results are expressed as means ± SD. Statistical significance within strains was determined
using a Student’s t-test or two-way ANOVA with multiple pairwise comparisons as appropri-
ate. In t-tests, if a sample failed the normality test, a rank t-test was used. In some cases of two-
way ANOVA, data were log-transformed to be normally distributed. Statistical analysis was
performed using Sigma-plot 13 software. A value of P < 0.05 was considered significant.
Results
To define a role for ATX in obesity and its complications, two animal models with reduced
ATX levels were established. Germline inactivation of the Enpp2 gene, encoding ATX, is
embryonically lethal, therefore systemic ATX reduction was achieved postnatally by breeding
mice with exons 3 and 4 of Enpp2 flanked by lox-P sites (fl/fl) to mice carrying the Cre recom-
binase under the control of the MX-1 promoter and activating the promoter in neonatal pups
with synthetic double-stranded RNA (MX1-Δ mice). Adipocyte-specific loss of ATX was
achieved with Cre recombinase under the control of the adiponectin promoter (Adipoq-Δ
mice). To elicit diet-induced obesity, littermate mice with or without the Cre recombinase
transgene were placed on HFD for 20 weeks.
Global reduction in Enpp2 expression was observed in MX1-Δ mice (S1A Fig; open bars),
with significantly lower levels of gene expression in kidney and spleen, and to a lesser extent in
heart and lung as compared to identically treated fl/fl littermate controls (S1 Fig; dark bars).
ATX activity was reduced by approximately 50% in plasma from MX1-Δ mice (S1B Fig). ATX
protein in subcutaneous and visceral adipose tissue was also lower in MX1-Δ as compared to
Autotaxin regulates complications of diet-induced obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0208099 February 7, 2019 4 / 17
fl/fl controls (S1C Fig). Together, these results confirm the effectiveness of the post-natal strat-
egy to reduce Enpp2 expression and ATX levels. No significant difference was observed
between the MX1-Δ and fl/fl mice in weight gain on HFD (Fig 1A) or fat and lean mass after
20 weeks of diet (Fig 1B) or adiposity index (13.2 ± 1.1 and 10.7 ± 4, n = 13; P = 0.43). Plasma
TG (42.2 ± 10.9 and 49.6 ± 31 mg/dl), non-esterified fatty acids (7.1 ± 1.8 and 8.9 ± 3.5 mg/dl)
or phospholipids (42.9 ± 8.0 and 60.5 ± 6 mg/dl) were similar in fl/fl and MX1-Δ mice
(mean ± SD; n = 4–6). No difference in heart, liver, lung or spleen weight was observed. Inter-
estingly, adipocyte cell size in both subcutaneous (Fig 1C) and visceral (Fig 1D) fat was signifi-
cantly smaller in the MX1-Δ mice. In parallel with the changes in cell size, inflammatory
marker expression in subcutaneous (Fig 1E) and visceral (Fig 1F) adipose tissue was also lower
in MX1-Δ animals. In particular, gene expression for tumor necrosis factor alpha (Tnfα, inter-
feron gamma (Ifnγ, interleukin-6 (IL-6) and chemokine CC motif ligand 2 (Mcp1) were all
reduced in the MX1-Δ mice. These findings suggest a role for ATX in regulating adipocyte size
and inflammatory gene expression during high fat feeding.
When on HFD, mice accumulate ectopic lipid in non-adipose tissues such as liver, resulting
in hepatic steatosis. We therefore investigated the impact of ATX deficiency on high fat diet
induced lipid accumulation in different tissues and observed differences in hepatic lipid accu-
mulation. Both hematoxolyin-eosin (H&E) and oil-red-O (ORO) staining for neutral lipid
reveal macrovesicular lipid accumulation in fl/fl control mice (Fig 2A). In contrast, MX1-Δ
Fig 1. Post-natal reductions in ATX expression alters adipocyte size and adipose tissue inflammation without an effect on body weight after HFD. A.) Average
body weight in fl/fl (dark circles) and MX1-Δ (open bars) male mice (n = 10-15/group at the indicated ages (weeks) after initiating HFD at 4 weeks of age. Mice were
placed on HFD at 4 weeks of age. B.) Body composition by fat and lean weight in fl/fl (dark circles) and MX1-Δ (open bars) male mice (n = 8–15 mice/group) after 20
weeks on HFD. C.) Cell area in subcutaneous adipose tissue in fl/fl (dark circles) and MX1-Δ (open bars) male mice (n = 4 mice; 100 cells/mouse) on normal chow or
after 20 weeks on HFD. D.) Cell area in visceral adipose tissue in fl/fl (dark circles) and MX1-Δ (open bars) male mice (n = 4 mice and 100 cells/mouse) on normal chow
or after 20 weeks on HFD. E.) Gene expression in subcutaneous adipose tissue from fl/fl (dark circles) and MX1-Δ (open bars) male mice after 20 weeks on HFD
(n = 3–4). F.) Inflammatory gene expression in visceral adipose tissue from fl/fl (dark circles) and MX1-Δ (open bars) male mice after 20 weeks on HFD (n = 3–4).
Comparison between genotypes was performed by t-test. � = P<0.05.
https://doi.org/10.1371/journal.pone.0208099.g001
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mice were strikingly protected from neutral lipid accumulation as visualized by ORO staining
(Fig 2B). Triglyceride levels were about 50% lower in liver from MX1-Δ mice (3.7 ± 2 versus
1.6 ± 0.5 per mg liver). Lipidomic profiling confirmed lower TG levels in livers from the MX1-
Δ mice, and revealed statistically significant increases in phosphatidylcholine (PC), sphingo-
myelin (SM) and phosphatidic acid (PA) in mice with reduced ATX (Fig 2C). No significant
differences in liver phosphatidylserine (PS) or phosphatidylethanolamine (PE) were observed.
The PC/PE ratio was not statiscally different in the fl/fl versus MX1-Δ livers (1.86 ± 0.44 versus
1.94 ± 0.39; mean ± SD; n = 3; P = 0.82). No difference in LPA receptor expression was observe
in livers (S2 Fig), and gene expression levels of several enzymes that regulate synthesis of cho-
lesterol steroids and other lipids was largely unaffected by reduced ATX, with the exception of
Cyp8B1 (cytochrome P450, family 8, subfamily B, polypeptide 1) that regulates intestinal bile
acid composition (S2 Fig). Along with alterations in lipid accumulation, substantially lower
gene expression of key pro-inflammatory markers, Tnfα and IL-12β, was observed with an
increase in IL-4 expression in MX1-Δ liver (Fig 2D).
Hepatic steatosis is associated with hepatic insulin resistance. Therefore, the systemic
impact of these changes was examined in fl/fl and MX1-Δ mice after 20 weeks on HFD. Base-
line glucose levels were similar in mice of both genotypes, however, glucose levels were sub-
stantially higher after an intraperitoneal glucose challenge in the fl/fl mice (Fig 3A and 3B). To
determine if these changes altered insulin sensitivity, mice were injected intraperitonealy with
Fig 2. Post-natal reduction in ATX expression protect from diet-induced changes in hepatic lipid accumulation. A.) Representative images (20X) of liver sections
stained with H&E (top) and ORO (bottom) from fl/fl mice after 20 weeks on HFD. B.) Representative images (20X) of liver sections stained with H&E (top) and ORO
(bottom) from MX1-Δ mice after 20 weeks on HFD. C.) Lipid profiles from liver of fl/fl (dark bars) and MX1-Δ (open bars) male mice after 20 weeks on HFD. Summed
results for indicated lipid species are displayed (n = 4/group). D.) Inflammatory gene expression in liver from fl/fl (dark bars) and MX1-Δ (open bars) male mice after 20
weeks on HFD (n = 3). Comparison between genotypes was performed by t-test. � = P<0.01.
https://doi.org/10.1371/journal.pone.0208099.g002
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Fig 3. Post-natal reductions in ATX expression alters glucose tolerance. A.) After HFD, fl/fl (dark bars) and MX1-Δ (open bars) male mice
were injected with glucose (2 g/kg body weight in isotonic saline, i.p.) and serial measurements of blood glucose levels were made at the indicated
times. Results are presented as mean ± SD (n = 4–5 mice). B.) Area under the curve (AUC) for glucose tolerance for each individual animal was
calculated and presented for individual mice. C.) Blood glucose levels at the indicated times after injection of insulin (1.5 U/kg body weight in
isotonic saline, i.p.) (n = 3). D.) Area under the curve (AUC) for insulin tolerance for each individual animal was calculated and presented for
individual mice. Box plots represent 25–75%iles; dark bar median. E.) Plasma levels (mean ±SD in pg/ml) of insulin, leptin, PAI-1, and resistin in
fl/fl (dark bars) and MX1-Δ (open bars) male mice after HFD (n = 5). F.) Plasma levels (mean ±SD in pg/ml) of IL-6, TNFα, and MCP-1 in fl/fl
(dark bars) and MX1-Δ (open bars) male mice after HFD (n = 6–7).
https://doi.org/10.1371/journal.pone.0208099.g003
Autotaxin regulates complications of diet-induced obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0208099 February 7, 2019 7 / 17
a dose of insulin that had minimal effect on glucose levels in fl/fl mice, but that caused a drop
in plasma glucose in MX1-Δ mice (Fig 3C and 3D), suggesting a difference in insulin sensitiv-
ity. Systemic levels of insulin were lower in nonfasting MX1-Δ mice with no change in plasma
leptin, PAI-1 or resistin levels (Fig 3E). In keeping with the reduced inflammation in both adi-
pose and liver tissue, plasma IL-6 levels were lower in MX1-Δ mice, however, no differences in
plasma TNFα, MCP-1 (Fig 1F) or adiponectin were found.
To elucidate the contribution of adipose–derived ATX to lipid remodeling associated with
obesity, the phenotype of the Adipoq-Δ mice fed HFD for 20 weeks was examined. No differ-
ence in kidney, spleen, lung, or heart Enpp2 expression was observed between Adipoq-Δ mice
and their fl/fl littermate controls (S3A Fig). ATX levels in subcutaneous fat were significantly
reduced in Adipoq-Δ mice, as was plasma ATX activity (S3 Fig). No difference in weight gain
over 20 weeks on HFD diet was noted between the two groups (Fig 4A), and lean and fat body
masses were similar (Fig 4B) as was adiposity index (16.3 ± 1.3 and 15.8 ± 0.7, n = 6 and 13;
P = 0.68). Plasma TG (47.9 ± 37 and 80 ± 59 mg/dl), non-esterified fatty acids (10.3 ± 2.5 and
11.6 ± 3.4 mg/dl) or phospholipids (147.4 ± 48.5 and 109 ± 38.2 mg/dl) were similar in fl/fl
and MX1-Δ mice (mean ± SD; n = 4–10). Organs weights were also not different. As was
observed with systemic ATX reduction, adipocyte-specific targeting of ATX resulted in smaller
adipocyte size in mice fed HFD (Fig 4F and 4G), although not in mice on normal chow. Subcu-
taneous adipose (Fig 4H) and visceral adipose (Fig 4I) from Adipoq-Δ mice also displayed
lower levels of some but not all inflammatory cytokine gene expression. In particular, gene
Fig 4. Loss of adipocyte ATX expression alters adipocyte size and adipose tissue inflammation without an effect on body weight after HFD. A.) Average
body weight in fl/fl (dark circles) and Adipoq-Δ (open bars) male mice (n = 20/group) t the indicated ages (weeks) after initiating HFD at 4 weeks of age. Mice
were placed on HFD at 4 weeks of age. B.) Body composition by fat and lean weight in fl/fl (dark circles) and Adipoq-Δ (open bars) male mice (n = 9–17) after
20 weeks on HFD. C.) Cell area in subcutaneous adipose tissue in fl/fl (dark circles) and Adipoq-Δ (open bars) male mice (n = 8) on normal chow or after 20
weeks on HFD. D.) Cell area in visceral adipose tissue in fl/fl (dark circles) and Adipoq-Δ (open bars) male mice (n = 8) on normal chow or after 20 weeks on
HFD. E.) Gene expression in subcutaneous adipose tissue from fl/fl (dark circles) and Adipoq-Δ (open bars) male mice after 20 weeks on HFD (n = 3–4). F.)
Inflammatory gene expression in visceral adipose tissue from fl/fl (dark circles) and Adipoq-Δ (open bars) male mice after 20 weeks on HFD (n = 3–4).
Comparison between genotypes was performed by t-test. � = P<0.05.
https://doi.org/10.1371/journal.pone.0208099.g004
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expression for Tnfα, IL-6, and Mcp-1 were lower in Adipoq-Δ subcutaneous fat (Fig 4E) and
for Tnfα and Ifnγ in Adipoq-Δ visceral fat (Fig 4F).
As was observed with the MX1-Δ mice, liver histology confirmed less lipid accumulation in
the Adipoq-Δ mice in comparison to their fl/fl littermate controls (Fig 5A and 5B) after HFD.
Lipidomic profiling demonstrated significantly lower TG levels in livers from the Adipoq-Δ
mice, along with statistically significant increases in phosphatidylcholine (PC), lysophosphati-
dylcholine (LPC), sphingomyelin (SM) and phosphatidic acid (PA) (Fig 5C). The PC/PE ratio
was statistically higher in the Adipoq-Δ liver (1.2 ± 0.08 versus 0.84 ± 0.2; mean ± SD in fl/fl
controls; n = 4; P = 0.036). No difference in LPA receptor or PPAR expression was observed
(S4 Fig). Likewise, expression of inflammatory genes IL-6, Tnfα, Mcp-1, or IL-4 (Fig 5D) was
unchanged in Adipoq-Δ liver. In keeping with the lack of difference in inflammation, the Adi-
poq-Δ mice fed HFD displayed no difference in glucose (Fig 6A and 6B) or insulin tolerance
(Fig 6C and 6D) in comparison to their littermate controls. Indeed, no difference was observed
in plasma levels of insulin, leptin, PAI-1, or resitin (Fig 6E). No differences in plasma IL-6,
TNFα or MCP-1 levels were observed between Adipoq-Δ and fl/fl mice after 20 weeks on HFD
(Fig 6F), although IL-6 trended lower (P = 0.06).
To understand the role of ATX in liver lipid remodeling, we sought to determine if the
effect required dietary intake of high fat or was a general property observed in models of
hepatic steatosis. In rodents, fasting increases hepatic TG as a result of re-esterification of free
fatty acids that exceeds the liver’s capacity to secrete TG. We investigated the role of ATX in
hepatic accumulation of TG as a consequence of fasting. As has been previously reported [32],
Fig 5. Loss of adipocyte ATX expression protects from diet-induced changes in hepatic lipid accumulation. A.) Representative images (20X) of liver
sections stained with H&E (top) and ORO (bottom) from fl/fl mice after 20 weeks on HFD. B.) Representative images 20x) of liver sections stained with H&E
(top) and ORO (bottom) from Adipoq-Δ mice after 20 weeks on HFD. C.) Lipid profiles from liver of fl/fl (dark bars; n = 4) and Adipoq-Δ (open bars; n = 4)
male mice after 20 weeks on HFD. Summed results for indicated lipid species are displayed. D.) Inflammatory gene expression in liver from fl/fl (dark circles)
and Adipoq-Δ (open bars) male mice after 20 weeks on HFD (n = 3). Comparison between genotypes was performed by t-test. � = P<0.01.
https://doi.org/10.1371/journal.pone.0208099.g005
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Fig 6. Loss of adipocyte ATX expression alter glucose tolerance. A.) After HFD, fl/fl (dark bars) and Adipoq-Δ (open bars) male mice were
injected with glucose (2 g/kg body weight in isotonic saline, i.p.) and serial measurements of blood glucose levels were made at the indicated times.
Results are presented as mean ± SD (n = 3–10). B.) Area under the curve (AUC) for glucose tolerance for each individual animal was calculated and
presented for individual mice. Box plots represent 25–75%iles; dark bar median. C.) Blood glucose levels at the indicated times after injection of
insulin (1.5 U/kg body weight in isotonic saline, i.p.) (n = 3–4). D.) Area under the curve (AUC) for insulin tolerance for each individual animal was
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twenty-four hours of fasting increased hepatic TG levels by approx. 3-fold from 1.6 ± 0.3
(n = 4) to 6.6 ± 1.7 (n = 7) per mg liver. No differences were observed between MX1-Δ and fl/fl
littermate controls (Fig 7A) or between fl/fl and Adipoq-Δ mice (Fig 7B) in accumulation of
hepatic TG after 24 hour fast, indicating the role of ATX in hepatic TG accumulation occurs in
calculated and presented for individual mice. Box plots represent 25–75%iles; dark bar median. E.) Plasma levels (mean ±SD in pg/ml) of insulin,
leptin, PAI-1, and resistin in fl/fl (dark bars) and Adipoq-Δ (open bars) male mice after HFD. F.) Plasma levels (mean ±SD in pg/ml) of IL-6, TNFα,
and MCP-1 in fl/fl (dark bars) and Adipoq-Δ (open bars) male mice after HFD (n = 7). Comparison between genotypes was performed by t-test. � =
P<0.05.
https://doi.org/10.1371/journal.pone.0208099.g006
Fig 7. Lack of effect of ATX on TG accumulation in liver after fasting or in plasma after oral lipid challenge. A.)
Liver TG levels after 24 hour fast in fl/fl (n = 4) and littermate control MX1-Δ (n = 4) male mice. Average values for
individual mice; box plots indicated 25–75%iles and bar median. B.) Liver TG levels after 24 hour fast in fl/fl and
littermate control Adipoq-Δ male mice (n = 6–7). C.) Plasma TG levels at the indicated time before (pre) or after oral
lipid administration (250 μl olive oil by gavage) in fl/fl and MX1-Δ mice (n = 4). D.) Plasma TG levels at the indicated
time before (pre) or after oral lipid administration (250 μl olive oil by gavage) in fl/fl and Adipoq-Δ mice (n = 3–10).
https://doi.org/10.1371/journal.pone.0208099.g007
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the context of dietary intake of fat. Therefore, we investigated whether ATX contributes to
lipid absorption and handling by following administration of a bolus of lipid. Again, no differ-
ences in plasma TG levels after oral lipid administration in either MX1-Δ (Fig 7C) or Adipoq-
Δ mice (Fig 7D) in comparison to their respective controls. In addition, we used a noninvasive
method to measure intestinal fat absorption using diets containing poorly absorbed sucrose
fatty acid esters to monitor intestinal absorption of dietary fat. Fat absorption was calculated
from the ratios of sucrose fatty acid ester to other fatty acids in diet and feces as analyzed by
mass spectrometry of fatty acid methyl esters. Using this method, no significant difference in
fat absorption was observed between male fl/fl and Adipoq-Δ mice (ratio of 0.48 ± 0.02 and
0.49 ± 0.08, respectively) on day 4 after SPB diet.
Based on these results, we sought to determine if the loss of ATX altered expression of
genes involved in fatty acid, diacylglcerol (DAG), PA and TG uptake/metabolism in the liver.
For this analysis, we examined livers from Adipoq-Δ and fl/fl mice to avoid confounding
effects of inflammatory changes observed in the MX1-Δ mice. Interesting, the adipose-specific
knock-down mice expressed lower levels of Cd36, diacylglycerol acyltransferase (Dgat1), and
Lpl and higher levels of Lipin1 in liver (Fig 8A), genes that regulate metabolic pathways as illus-
trated in Fig 8B.
Discussion
Recent escalations in obesity have profound medical and socioeconomic implications.[33, 34]
Excessive visceral fat deposition has been demonstrated to be strongly correlated with meta-
bolic syndrome and cardiovascular diseases.[34] Moreover, the increased cardiovascular mor-
tality in obese patients may not be completely explained by associated risk factors such as
dyslipidemia (typically elevated TG and lower high density lipoproteins), hyperglycemia, insu-
lin resistance and hypertension. Obesity is also characterized by a chronic sub-acute inflamma-
tory state with macrophage infiltration in fat and the production of inflammatory mediators
by adipose tissue [35]. In this work, we identify ATX as a mediator of the inflammatory
Fig 8. ATX regulates gene expression of enzymes that regulate phospholipid and triglyceride synthesis. A.) Gene expression in liver of fl/fl (dark bars)
and Adipoq-Δ (open bars) male mice after 20 weeks on HFD (n = 3). B.) Summary of glycerophospholipids in liver influenced by ATX (arrows indicated
changes in mice with reduced ATX expression) and pathways involved in their production.
https://doi.org/10.1371/journal.pone.0208099.g008
Autotaxin regulates complications of diet-induced obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0208099 February 7, 2019 12 / 17
response in the context of diet-induced obesity and importantly suggest that adipose-derived
ATX a key regulator of lipid accumulation and/or remodeling that accompanies hepatic steato-
sis associated with obesity.
A comparison of the phenotypes of HFD-fed mice with global (MX1-Δ) and adipose-spe-
cific (Adipoq-Δ) reductions in ATX expression yield interesting similarities and differences
following HFD feeding. In both models, the loss of ATX protected from diet-induced increases
in adipose cell size and adipose inflammation. Likewise, mice displayed less HFD-associated
accumulation of lipid in liver. Interesting, the global but not the adipose-specific deficiency
had attenuated hepatic inflammation and were protected from insulin resistance. These obser-
vations could potentially reflect differences in local actions of ATX on liver inflammation (e.g.
through resident macrophage or other cells) as plasma ATX was reduced by approximately
50% in both models. We did not address whether the effect of adipose ATX on liver lipid accu-
mulation is a direct effect of adipose-derived ATX or indirect through changes in adipose
inflammation.
ATX production can be stimulated by TNFα [36], likely in a nuclear factor-kappa B-depen-
dent manner. Our results are consistent with a role for ATX in promoting local and systemic
inflammation, the latter of which correlates with hepatic TG accumulation and glucose toler-
ance. The primary function of ATX is likely to generate bioactive LPA, which is known to pro-
mote inflammatory. Adipose-derived ATX predominately influences adipose inflammation,
likely through local signaling effects, whereas broader effects of MX1-mediated global reduc-
tion in ATX were observed in both fat and liver tissue and translated into reductions in sys-
temic, plasma levels of inflammatory mediators. The inflammatory changes that occur with
obesity can in turn influence both insulin resistance and liver TG accumulation. For example,
TNF-α over expression with obesity signals through IκB kinase β to phosphorylate IRS-1 and
IRS-2 to promote insulin resistance [37, 38], which in turn promotes liver TG accumulation.
Our observations of lower TNFα in mice with postnatal reductions in ATX may oppose this
effect during HFD feeding. Likewise, the plasma insulin levels may promote adipose tissue
lipolysis and reduce de novo liver synthesis. Although, interestingly, adipose-specific deletion
of ATX altered liver lipids without a pronounced effect on liver inflammation.
Mice with global post-natal or adipose-specific deficiency of ATX were protected from
accumulation of neutral lipids in the liver when fed high fat diet. Mass spectrometry based
lipid profiling indicated that this phenotype was associated with steady state decreases in liver
TG levels but significant increases in levels of several species of glycerophospholipids, includ-
ing liver PC levels. The ratio PC:PE regulates membrane integrity, and decreases in the ratio
elicits liver injury [39]. A significantly higher PC:PE ratio was observed in Adipoq-Δ mice,
which lacked dramatic changes in liver inflammation that can impact lipid metabolism as
described above. Results from liver RNA expression profiling in the suggest that alterations in
adipose ATX levels are associated with changes in levels of expression of some key enzymes
that catalyze critical steps that determine the substrate supply of phosphatidic acid and diacyl-
glycerol for synthesis of phospholipids and TG, including Cd36, Dgat1, Lipin1, and Lpl. These
findings could potentially explain the alterations in phospholipid accumulation in liver (Fig
8B). While genetic deficiency of ATX is protective against hepatic steatosis and reduces hepatic
inflammation in mice, potent ATX inhibition had no effect on CCl4-induced liver fibrosis and
choline-deficient amino acid-defined diet-induced liver injury in rats [40] and so it is possible
that ATX does not contribute to liver dysfunction in these models.
LPA has a plethora of cellular effects that can regulate glucose metabolism and insulin sig-
naling. It can directly inhibit islet cell secretion of insulin and increases glucose transport in
muscle and fat [41]. LPA attenuates insulin signaling in the liver via LPAR3 by impairing
PI3-kinase activation and glucokinase expression, the rate limiting enzyme in hepatic glucose
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utilization [42]. It is possible that the effects of global-reductions in ATX reflect these or other
roles of LPA.
Our results indicate that while ATX has roles in regulating adipocyte size and inflammatory
gene expression inducible systemic or adipocyte specific ATX deficiency has no effect on
expansion of adipose depots during high fat feeding. Our finding that ATX regulates ectopic
fat accumulation in the liver suggests that pharmacological inhibition of ATX might be effec-
tive in management of this growing complication of obesity and metabolic syndrome.
Supporting information
S1 Table. TaqMan gene expression (ThermoFisher) assays. Real-time quantitative PCR pre-
designed assays used to measure mRNA expression.
(PPTX)
S1 Fig. Post-natal reductions in ATX expression with MX1-Cre mediated deletion. A.) Rel-
ative gene expression in different tissues in fl/fl (dark bars) and MX1-Δ (open bars) male mice
(n = 6). B.) Immunoblot analysis of ATX protein in plasma (1 μl; bottom loading
control = albumin) and plasma ATX activity (μmol/min/ml) in fl/fl (dark bars) and MX1-Δ
(open bars) male mice (n = 6–7). C.) Immunoblot analysis of ATX protein expression in sub-
cutaneous fat (loading control β-actin) and quantification of ATX expression in fat fl/fl (dark
bars) and MX1-Δ (open bars) male mice.
(PPTX)
S2 Fig. Effect of global post-natal reductions in ATX on liver gene expression. Relative
gene expression in fl/fl (dark bars) and MX1-Δ (open bars) male mice (n = 3).
(PPTX)
S3 Fig. Adipose-specific reductions in ATX expression. Relative gene expression in different tis-
sues in fl/fl (dark bars) and Adipoq-Δ (open bars) male mice (n = 5–6). B.) ATX protein expres-
sion in subcutaneous and visceral fat. C.) Plasma ATX activity (μmols/min/ml) in fl/fl (dark bars)
and Adipoq-Δ (open bars) male mice (n = 8). D. PPAR gene expression in subcutaneous adipose
and (E) visceral adipose from fl/fl (dark bars) and Adipoq-Δ (open bars) male mice (n = 3).
(PPTX)
S4 Fig. Effect of adipose-specific reductions in ATX on liver gene expression. Relative gene
expression in fl/fl (dark bars) and Adipoq-Δ (open bars) male mice (n = 3).
(PPTX)
Author Contributions
Conceptualization: J. Anthony Brandon, Maria Kraemer, Andrew J. Morris, Susan S. Smyth.
Data curation: Maria Kraemer, Suchismita Halder, Andrew J. Morris, Susan S. Smyth.
Formal analysis: J. Anthony Brandon, Maria Kraemer, Suchismita Halder, Andrew J. Morris,
Susan S. Smyth.
Funding acquisition: Andrew J. Morris, Susan S. Smyth.
Investigation: J. Anthony Brandon, Maria Kraemer, Julia Vandra, Margo Ubele, Andrew J.
Morris, Susan S. Smyth.
Methodology: Julia Vandra, Suchismita Halder, Margo Ubele, Andrew J. Morris, Susan S.
Smyth.
Autotaxin regulates complications of diet-induced obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0208099 February 7, 2019 14 / 17
Project administration: J. Anthony Brandon, Andrew J. Morris, Susan S. Smyth.
Resources: Andrew J. Morris, Susan S. Smyth.
Supervision: Andrew J. Morris, Susan S. Smyth.
Writing – original draft: Andrew J. Morris, Susan S. Smyth.
Writing – review & editing: Julia Vandra, Suchismita Halder, Margo Ubele, Andrew J. Mor-
ris, Susan S. Smyth.
References
1. David M, Wannecq E, Descotes F, Jansen S, Deux B, Ribeiro J, et al. Cancer cell expression of auto-
taxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation
of osteoclasts. PloS one. 2010; 5(3):e9741. https://doi.org/10.1371/journal.pone.0009741 PMID:
20305819
2. Yukiura H, Hama K, Nakanaga K, Tanaka M, Asaoka Y, Okudaira S, et al. Autotaxin regulates vascular
development via multiple lysophosphatidic acid (LPA) receptors in zebrafish. The Journal of biological
chemistry. 2011; 286(51):43972–83. https://doi.org/10.1074/jbc.M111.301093 PMID: 21971049
3. Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, et al. Autotaxin stabilizes blood vessels and
is required for embryonic vasculature by producing lysophosphatidic acid. The Journal of biological
chemistry. 2006; 281(35):25822–30. https://doi.org/10.1074/jbc.M605142200 PMID: 16829511
4. van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradere JP, et al. Autotaxin, a
secreted lysophospholipase D, is essential for blood vessel formation during development. Molecular
and cellular biology. 2006; 26(13):5015–22. https://doi.org/10.1128/MCB.02419-05 PMID: 16782887
5. Nakagawa H, Ikeda H, Nakamura K, Ohkawa R, Masuzaki R, Tateishi R, et al. Autotaxin as a novel
serum marker of liver fibrosis. Clinica chimica acta; international journal of clinical chemistry. 2011; 412
(13–14):1201–6. https://doi.org/10.1016/j.cca.2011.03.014 PMID: 21419756
6. Oikonomou N, Mouratis MA, Tzouvelekis A, Kaffe E, Valavanis C, Vilaras G, et al. Pulmonary autotaxin
expression contributes to the pathogenesis of pulmonary fibrosis. American journal of respiratory cell
and molecular biology. 2012; 47(5):566–74. https://doi.org/10.1165/rcmb.2012-0004OC PMID:
22744859
7. Bain G, Shannon KE, Huang F, Darlington J, Goulet L, Prodanovich P, et al. Selective Inhibition of Auto-
taxin Is Efficacious in Mouse Models of Liver Fibrosis. The Journal of pharmacology and experimental
therapeutics. 2017; 360(1):1–13. https://doi.org/10.1124/jpet.116.237156 PMID: 27754931
8. Park GY, Lee YG, Berdyshev E, Nyenhuis S, Du J, Fu P, et al. Autotaxin production of lysophosphatidic
acid mediates allergic asthmatic inflammation. American journal of respiratory and critical care medi-
cine. 2013; 188(8):928–40. https://doi.org/10.1164/rccm.201306-1014OC PMID: 24050723
9. Nochi H, Tomura H, Tobo M, Tanaka N, Sato K, Shinozaki T, et al. Stimulatory role of lysophosphatidic
acid in cyclooxygenase-2 induction by synovial fluid of patients with rheumatoid arthritis in fibroblast-like
synovial cells. Journal of immunology (Baltimore, Md: 1950). 2008; 181(7):5111–9.
10. Benesch MG, Zhao YY, Curtis JM, McMullen TP, Brindley DN. Regulation of autotaxin expression and
secretion by lysophosphatidate and sphingosine 1-phosphate. Journal of lipid research. 2015; 56
(6):1134–44. https://doi.org/10.1194/jlr.M057661 PMID: 25896349
11. Benesch MG, Tang X, Dewald J, Dong WF, Mackey JR, Hemmings DG, et al. Tumor-induced inflam-
mation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer
progression. FASEB journal: official publication of the Federation of American Societies for Experimen-
tal Biology. 2015; 29(9):3990–4000.
12. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. LPA receptors: subtypes and biologi-
cal actions. Annu Rev Pharmacol Toxicol. 2010; 50:157–86. https://doi.org/10.1146/annurev.pharmtox.
010909.105753 PMID: 20055701
13. Tigyi G. Physiological responses to lysophosphatidic acid and related glycero-phospholipids. Prosta-
glandins Other Lipid Mediat. 2001; 64(1–4):47–62. PMID: 11324707
14. Rai V, Toure F, Chitayat S, Pei R, Song F, Li Q, et al. Lysophosphatidic acid targets vascular and onco-
genic pathways via RAGE signaling. The Journal of experimental medicine. 2012; 209(13):2339–50.
https://doi.org/10.1084/jem.20120873 PMID: 23209312
15. Hausmann J, Kamtekar S, Christodoulou E, Day JE, Wu T, Fulkerson Z, et al. Structural basis of sub-
strate discrimination and integrin binding by autotaxin. Nat Struct Mol Biol. 2011; 18(2):198–204. https://
doi.org/10.1038/nsmb.1980 PMID: 21240271
Autotaxin regulates complications of diet-induced obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0208099 February 7, 2019 15 / 17
16. Fulkerson Z, Wu T, Sunkara M, Kooi CV, Morris AJ, Smyth SS. Binding of autotaxin to integrins local-
izes lysophosphatidic acid production to platelets and mammalian cells. The Journal of biological chem-
istry. 2011; 286(40):34654–63. https://doi.org/10.1074/jbc.M111.276725 PMID: 21832043
17. Wu T, Kooi CV, Shah P, Charnigo R, Huang C, Smyth SS, et al. Integrin-mediated cell surface recruit-
ment of autotaxin promotes persistent directional cell migration. FASEB journal: official publication of
the Federation of American Societies for Experimental Biology. 2014; 28(2):861–70.
18. Leblanc R, Lee SC, David M, Bordet JC, Norman DD, Patil R, et al. Interaction of platelet-derived auto-
taxin with tumor integrin alphaVbeta3 controls metastasis of breast cancer cells to bone. Blood. 2014;
124(20):3141–50. https://doi.org/10.1182/blood-2014-04-568683 PMID: 25277122
19. Rancoule C, Dusaulcy R, Treguer K, Gres S, Guigne C, Quilliot D, et al. Depot-specific regulation of
autotaxin with obesity in human adipose tissue. Journal of physiology and biochemistry. 2012; 68
(4):635–44. https://doi.org/10.1007/s13105-012-0181-z PMID: 22644624
20. Dusaulcy R, Rancoule C, Gres S, Wanecq E, Colom A, Guigne C, et al. Adipose-specific disruption of
autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. Journal of lipid
research. 2011; 52(6):1247–55. https://doi.org/10.1194/jlr.M014985 PMID: 21421848
21. Ferry G, Tellier E, Try A, Gres S, Naime I, Simon MF, et al. Autotaxin is released from adipocytes, cata-
lyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expres-
sion with adipocyte differentiation and obesity. The Journal of biological chemistry. 2003; 278
(20):18162–9. https://doi.org/10.1074/jbc.M301158200 PMID: 12642576
22. Sun S, Wang R, Song J, Guan M, Li N, Zhang X, et al. Blocking gp130 signaling suppresses autotaxin
expression in adipocytes and improves insulin sensitivity in diet-induced obesity. Journal of lipid
research. 2017; 58(11):2102–13. https://doi.org/10.1194/jlr.M075655 PMID: 28874440
23. Boucher J, Quilliot D, Praderes JP, Simon MF, Gres S, Guigne C, et al. Potential involvement of adipo-
cyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin
expression. Diabetologia. 2005; 48(3):569–77. https://doi.org/10.1007/s00125-004-1660-8 PMID:
15700135
24. Nishimura S, Nagasaki M, Okudaira S, Aoki J, Ohmori T, Ohkawa R, et al. ENPP2 contributes to adi-
pose tissue expansion and insulin resistance in diet-induced obesity. Diabetes. 2014; 63(12):4154–64.
https://doi.org/10.2337/db13-1694 PMID: 24969110
25. Simon MF, Daviaud D, Pradere JP, Gres S, Guigne C, Wabitsch M, et al. Lysophosphatidic acid inhibits
adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome
proliferator-activated receptor gamma2. The Journal of biological chemistry. 2005; 280(15):14656–62.
https://doi.org/10.1074/jbc.M412585200 PMID: 15710620
26. Federico L, Ren H, Mueller PA, Wu T, Liu S, Popovic J, et al. Autotaxin and its product lysophosphatidic
acid suppress brown adipose differentiation and promote diet-induced obesity in mice. Mol Endocrinol.
2012; 26(5):786–97. https://doi.org/10.1210/me.2011-1229 PMID: 22474126
27. National Research Council Committee for the Update of the Guide for the C, Use of Laboratory A. The
National Academies Collection: Reports funded by National Institutes of Health. In: th, editor. Guide for
the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US) National
Academy of Sciences.; 2011. https://doi.org/10.1258/la.2010.010031
28. Wang CY, Liao JK. A mouse model of diet-induced obesity and insulin resistance. Methods in molecular
biology (Clifton, NJ). 2012; 821:421–33.
29. Jandacek RJ, Heubi JE, Tso P. A novel, noninvasive method for the measurement of intestinal fat
absorption. Gastroenterology. 2004; 127(1):139–44. PMID: 15236180
30. Holcapek M, Liebisch G, Ekroos K. Lipidomic Analysis. Analytical chemistry. 2018; 90(7):4249–57.
https://doi.org/10.1021/acs.analchem.7b05395 PMID: 29543437
31. Simons B, Kauhanen D, Sylvanne T, Tarasov K, Duchoslav E, Ekroos K. Shotgun Lipidomics by
Sequential Precursor Ion Fragmentation on a Hybrid Quadrupole Time-of-Flight Mass Spectrometer.
Metabolites. 2012; 2(1):195–213. https://doi.org/10.3390/metabo2010195 PMID: 24957374
32. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-acti-
vated receptor alpha mediates the adaptive response to fasting. The Journal of clinical investigation.
1999; 103(11):1489–98. https://doi.org/10.1172/JCI6223 PMID: 10359558
33. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults,
1999–2008. Jama. 2010; 303(3):235–41. https://doi.org/10.1001/jama.2009.2014 PMID: 20071471
34. Ogden CL, Carroll MD, Flegal KM. Prevalence of obesity in the United States. Jama. 2014; 312(2):189–
90.
35. Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other
nutraceuticals. Annu Rev Nutr. 2010; 30:173–99. https://doi.org/10.1146/annurev.nutr.012809.104755
PMID: 20420526
Autotaxin regulates complications of diet-induced obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0208099 February 7, 2019 16 / 17
36. Nikitopoulou I, Oikonomou N, Karouzakis E, Sevastou I, Nikolaidou-Katsaridou N, Zhao Z, et al. Auto-
taxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. The
Journal of experimental medicine. 2012; 209(5):925–33. https://doi.org/10.1084/jem.20112012 PMID:
22493518
37. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, et al. Insulin/IGF-1 and TNF-alpha stimulate
phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. The Journal of clinical investigation.
2001; 107(2):181–9. https://doi.org/10.1172/JCI10934 PMID: 11160134
38. Nieto-Vazquez I, Fernandez-Veledo S, Kramer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insu-
lin resistance associated to obesity: the link TNF-alpha. Archives of physiology and biochemistry. 2008;
114(3):183–94. https://doi.org/10.1080/13813450802181047 PMID: 18629684
39. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, et al. The ratio of phosphatidylcholine to
phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell metabolism. 2006; 3
(5):321–31. https://doi.org/10.1016/j.cmet.2006.03.007 PMID: 16679290
40. Baader M, Bretschneider T, Broermann A, Rippmann JF, Stierstorfer B, Kuttruff CA, et al. Characteriza-
tion of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of
advanced stages of liver fibrosis. British journal of pharmacology. 2018; 175(4):693–707. https://doi.
org/10.1111/bph.14118 PMID: 29197066
41. Yang F, Chen GX. Production of extracellular lysophosphatidic acid in the regulation of adipocyte func-
tions and liver fibrosis. World journal of gastroenterology. 2018; 24(36):4132–51. https://doi.org/10.
3748/wjg.v24.i36.4132 PMID: 30271079
42. Fayyaz S, Japtok L, Schumacher F, Wigger D, Schulz TJ, Haubold K, et al. Lysophosphatidic Acid
Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased
in Obesity. Cellular physiology and biochemistry: international journal of experimental cellular physiol-
ogy, biochemistry, and pharmacology. 2017; 43(2):445–56.
Autotaxin regulates complications of diet-induced obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0208099 February 7, 2019 17 / 17
